कृपया अन्य खोज का प्रयास करें
AusCann Group Holdings Ltd engages in the development and commercialization of cannabinoid-derived therapeutic products for humans and animals in Australia and internationally. Its principal product includes the novel tetrahydrocannabinol and cannabidiol (THC/CBD), a powder-based hard-shell capsules based on AusCann’s Neuvis platform for the treatment of pain and related indications. The company is also involved in the research and development of medicinal cannabis. It offers its products to healthcare professionals and veterinarians. AusCann Group Holdings Ltd is based in West Perth, Australia.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Marc Russo | - | 2020 | Chief Medical Advisor & Chairman of Medical Advisory Board |
Peter Gonski | - | 2020 | Member of Medical Advisory Board |
Robert Clifford | - | 2021 | Independent Non-Executive Director |
Peter Georgius | - | 2020 | Member of Medical Advisory Board |
Sachin Shetty | - | 2020 | Member of Medical Advisory Board |
Brett Anthony Mitchell | 51 | 2023 | Independent Non-Executive Director |
Andrew Chapman | 49 | 2024 | Non-executive Chairman |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है